Nanotechnology Identifies Peptide "Fingerprint" in Both Forms of ALS

User rating: 4.5 / 5 after 4 vote(s)

A nanospray emitter developed by chemist Troy Wood has identified a common molecular signature in familial and sporadic forms of Lou Gehrigacutes disease.
A nanospray emitter developed by chemist Troy Wood has identified a common molecular signature in familial and sporadic forms of Lou Gehrig's disease.

A nanotechnology developed by a University at Buffalo professor has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.


Full story »
All News summaries from Nanotechnology news
All News summaries for September 04, 2007
Goto Archive PhysOrg Forum Goto Archive Video Goto Archive Editorials Goto Archive Free Magazines Goto Archive Newsletter

News Archive